Actionable news
All posts from Actionable news
Actionable news in MRK: MERCK & CO. Inc,

Merck’s Keytruda Study in Bladder Cancer Stopped as Goal Met

Merck & Co.’s study of its Keytruda drug in patients with previously treated bladder cancer was stopped on the recommendation of a panel after hitting its primary goal in overall survival.

Keytruda was superior compared to standard chemotherapy in the final-stage trial of 542 patients with advanced urothelial cancer...